4.5 Review

Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy

期刊

FUTURE MEDICINAL CHEMISTRY
卷 3, 期 5, 页码 567-597

出版社

FUTURE SCI LTD
DOI: 10.4155/FMC.11.22

关键词

-

向作者/读者索取更多资源

Signal transducer and activator of transcription 3 (STAT3) is an oncogenic protein whose inhibition is sought for the prevention and treatment of cancer. In this review, the validated therapeutic strategy to block aberrant activity of STAT3 in many tumor cell lines is evaluated by presenting the most promising inhibitors to date. The compounds are discussed in classes based on their different mechanisms of action, which are critically explained. In addition, their future clinical development as anticancer agents is considered. Furthermore, the efforts devoted to the comprehension of the structure activity relationships and to the identification of the biological effects are brought to attention. The synthetic and technological approaches recently developed to overcome the difficulties in the obtainment of clinically suitable drugs are also presented.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Chemistry, Medicinal

Virtual screening and crystallographic studies reveal an unexpected g-lactone derivative active against MptpB as a potential antitubercular agent

Giulia Cazzaniga, Matteo Mori, Fiorella Meneghetti, Laurent R. Chiarelli, Giovanni Stelitano, Isabella Caligiuri, Flavio Rizzolio, Samuele Ciceri, Giulio Poli, Diana Staver, Gabriella Ortore, Tiziano Tuccinardi, Stefania Villa

Summary: A new compound with significant enzymatic activity against protein tyrosine phosphatase B, which interferes with host immune responses, has been discovered as a potential treatment for tuberculosis.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2022)

Review Biochemistry & Molecular Biology

Insights on the Modulation of SIRT5 Activity: A Challenging Balance

Matteo Mori, Giulia Cazzaniga, Fiorella Meneghetti, Stefania Villa, Arianna Gelain

Summary: This article provides an overview of interesting modulators of SIRT5, aiming to contribute to further developments in this field.

MOLECULES (2022)

Article Chemistry, Medicinal

Synthesis and Assessment of the In Vitro and Ex Vivo Activity of Salicylate Synthase (Mbti) Inhibitors as New Candidates for the Treatment of Mycobacterial Infections

Matteo Mori, Giovanni Stelitano, Anna Griego, Laurent R. Chiarelli, Giulia Cazzaniga, Arianna Gelain, Elena Pini, Marina Camera, Paola Canzano, Andrea Fumagalli, Edoardo Scarpa, Chiara Cordiglieri, Loris Rizzello, Stefania Villa, Fiorella Meneghetti

Summary: Tuberculosis is one of the most dangerous infectious diseases worldwide, and new therapeutic options are urgently needed. In this study, a series of analogues of the MbtI inhibitor were synthesized, and the most effective compound against TB was identified. Furthermore, a fluorescence-based screening test was established to accelerate the discovery of new anti-TB drugs.

PHARMACEUTICALS (2022)

Article Chemistry, Physical

Synthesis, crystal structure, Hirshfeld surface, computational and antibacterial studies of a 9-phenanthrenecarboxaldehyde-based thiodihydropyrimidine derivative

Alakbar Huseynzada, Matteo Mori, Fiorella Meneghetti, Aygun Israyilova, Gamze Tuzun, Koray Sayin, Laurent R. Chiarelli, Ceylan Mutlu, Mustafa Demiralp, Ulviyya Hasanova, Vagif Abbasov

Summary: The synthesis of a novel biologically active 3,4-dihydropyrimidin-2(1H)-thione derivative was reported, and the structure of the synthesized compound was investigated. The antibacterial effect of the compound was evaluated, and computational studies were performed to analyze its properties.

JOURNAL OF MOLECULAR STRUCTURE (2022)

Article Chemistry, Organic

Synthesis and Conformational Analysis of Hydantoin-Based Universal Peptidomimetics

Alessio M. Caramiello, Maria Cristina Bellucci, Gaetano Cristina, Carlo Castellano, Fiorella Meneghetti, Matteo Mori, Francesco Secundo, Fiorenza Viani, Alessandro Sacchetti, Alessandro Volonterio

Summary: This study presents the synthesis of a collection of enantiomerically pure, systematically substituted hydantoins as structural privileged universal mimetic scaffolds. The synthesis relies on a selective condensation/cyclization process between isocyanates and aspartic acid diesters, followed by hydrolysis/coupling reactions with amines. Conformational studies showed that the hydantoin-based peptidomimetics are capable of projecting their substituents in positions superimposable to common protein secondary structures.

JOURNAL OF ORGANIC CHEMISTRY (2022)

Editorial Material Chemistry, Medicinal

An introduction to the newest member of our editorial board, Associate Professor Fiorella Meneghetti

Fiorella Meneghetti

FUTURE MEDICINAL CHEMISTRY (2022)

Article Crystallography

Crystal Structure, Hirshfeld Surface Analysis, In-Silico and Antimycotic Investigations of Methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylate

Alakbar Huseynzada, Matteo Mori, Fiorella Meneghetti, Aygun Israyilova, Elif Guney, Koray Sayin, Laurent R. Chiarelli, Mustafa Demiralp, Ulviyya Hasanova, Vagif Abbasov

Summary: In this study, methyl 6-methyl-4-(4-nitrophenyl)-2-oxo-1,2-dihydropyrimidine-5-carboxylate 2 was prepared by the regioselective oxidative dehydrogenation of dihydropyrimidine derivative 1 in the presence of cerium ammonium nitrate. The tautomeric form of compound 2 was determined through single-crystal X-ray diffraction (SC-XRD). Non-covalent interactions and their impact on the crystal structure were analyzed using Hirshfeld surface and enrichment ratio analyses. Furthermore, the antimycotic activity of compounds 1 and 2 against Candida albicans, Aspergillus flavus, and Aspergillus niger was investigated and compared to fluconazole. Computational investigations provided insights into the better activity of compound 2 compared to its synthetic precursor.

CRYSTALS (2023)

Article Pharmacology & Pharmacy

Targeting Siderophore-Mediated Iron Uptake in M. abscessus: A New Strategy to Limit the Virulence of Non-Tuberculous Mycobacteria

Matteo Mori, Giovanni Stelitano, Giulia Cazzaniga, Arianna Gelain, Andrea Tresoldi, Mario Cocorullo, Martina Roversi, Laurent R. R. Chiarelli, Martina Tomaiuolo, Pietro Delre, Giuseppe F. F. Mangiatordi, Anna Griego, Loris Rizzello, Alberto Cassetta, Sonia Covaceuszach, Stefania Villa, Fiorella Meneghetti

Summary: Targeting specific pathogenic mechanisms, including iron acquisition, shows potential for the development of new drugs against M. abscessus. In this study, the Salicylate Synthase (SaS) enzyme of Mab was investigated as a target for inhibitors of siderophore production. Compound 1 was identified as a lead inhibitor, exhibiting strong activity against Mab-SaS. Computational studies revealed key interactions between compound 1 and the enzyme, suggesting the potential for rational design of more potent derivatives.

PHARMACEUTICS (2023)

Article Chemistry, Organic

Methyl 5-(2-Fluoro-4-nitrophenyl)furan-2-carboxylate

Matteo Mori, Andrea Tresoldi, Giulia Cazzaniga, Fiorella Meneghetti, Stefania Villa

Summary: This study presents the crystal structure analysis of a new class of antimycobacterial agents, providing important data support for further research.

MOLBANK (2022)

Article Chemistry, Organic

5-(4-Nitrophenyl)furan-2-carboxylic Acid

Matteo Mori, Andrea Tresoldi, Stefania Villa, Giulia Cazzaniga, Marco Bellinzoni, Fiorella Meneghetti

Summary: This article describes a new class of antitubercular agents, 5-phenyl-furan-2-carboxylic acids, and provides analysis methods and results for the compound.

MOLBANK (2022)

Review Biochemistry & Molecular Biology

Iron Acquisition and Metabolism as a Promising Target for Antimicrobials (Bottlenecks and Opportunities): Where Do We Stand?

Giovanni Stelitano, Mario Cocorullo, Matteo Mori, Stefania Villa, Fiorella Meneghetti, Laurent Roberto Chiarelli

Summary: The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) infections is a crucial challenge in the scientific community. This review discusses innovative strategies to hinder iron acquisition in bacteria, including interesting targets and chemical entities that interfere with their function. The mechanism of action, pharmacodynamics, pharmacokinetics, and toxicological properties of each drug candidate are also reviewed. Comprehensive knowledge in this area may lead to the discovery of newer antibiotics to combat antimicrobial resistance effectively.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study

Samuele Ciceri, Diego Colombo, Enrico M. A. Fassi, Patrizia Ferraboschi, Giovanni Grazioso, Paride Grisenti, Marco Iannone, Carlo Castellano, Fiorella Meneghetti

Summary: Elagolix sodium salt is the first orally active non-peptide gonadotropin-releasing hormone receptor antagonist for the treatment of hormone dependent diseases. A detailed NMR investigation was conducted to analyze the drug and its synthetic intermediates, allowing for the complete assignment of the NMR signals and determination of the stereochemical profile of the atropisomers. These results contribute to the understanding of atropisomerism in drug discovery and can be applied in the design of safer and more effective analogs.

MOLECULES (2023)

Article Pharmacology & Pharmacy

Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid

Alessandro Ratti, Enrico M. A. Fassi, Fabio Forlani, Matteo Mori, Federica Villa, Francesca Cappitelli, Jacopo Sgrignani, Gabriella Roda, Andrea Cavalli, Stefania Villa, Giovanni Grazioso

Summary: Bacterial biofilm is a major cause of persistent infection and antibiotic resistance. This study investigates the antibiofilm properties and mode of action of ellagic acid (EA), a natural polyphenol. The researchers propose that EA disrupts the bacterial redox homeostasis mediated by the NADH:quinone oxidoreductase enzyme WrbA, leading to its antibiofilm activity. These findings provide new insights into the potential use of EA for treating biofilm-related infections.

PHARMACEUTICS (2023)

Article Biochemistry & Molecular Biology

Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA

Alessandro Ratti, Enrico M. A. Fassi, Fabio Forlani, Maurizio Zangrossi, Matteo Mori, Francesca Cappitelli, Gabriella Roda, Stefania Villa, Federica Villa, Giovanni Grazioso

Summary: This study used a computational model to screen natural compounds and identified purpurogallin and NZ034 as potential antibiofilm compounds at a non-lethal concentration of 0.5μM.

ANTIOXIDANTS (2023)

暂无数据